BG62093B1 - Инхибитори на hiv протеаза - Google Patents
Инхибитори на hiv протеаза Download PDFInfo
- Publication number
- BG62093B1 BG62093B1 BG100643A BG10064396A BG62093B1 BG 62093 B1 BG62093 B1 BG 62093B1 BG 100643 A BG100643 A BG 100643A BG 10064396 A BG10064396 A BG 10064396A BG 62093 B1 BG62093 B1 BG 62093B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- hiv
- compound
- aids
- pharmaceutically acceptable
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16801393A | 1993-12-15 | 1993-12-15 | |
| US17047593A | 1993-12-20 | 1993-12-20 | |
| PCT/US1994/014187 WO1995016688A1 (fr) | 1993-12-15 | 1994-12-12 | Inhibiteurs de la protease du vih |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG100643A BG100643A (bg) | 1997-02-28 |
| BG62093B1 true BG62093B1 (bg) | 1999-02-26 |
Family
ID=26863718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG100643A BG62093B1 (bg) | 1993-12-15 | 1996-06-05 | Инхибитори на hiv протеаза |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5646148A (fr) |
| EP (1) | EP0734387B1 (fr) |
| JP (1) | JP3000564B2 (fr) |
| KR (1) | KR100234863B1 (fr) |
| CN (1) | CN1046727C (fr) |
| AT (1) | ATE215952T1 (fr) |
| AU (1) | AU692509B2 (fr) |
| BG (1) | BG62093B1 (fr) |
| BR (1) | BR9408305A (fr) |
| CA (1) | CA2178760C (fr) |
| CZ (1) | CZ288312B6 (fr) |
| DE (1) | DE69430385T2 (fr) |
| ES (1) | ES2174921T3 (fr) |
| FI (1) | FI962488A0 (fr) |
| HU (1) | HUT74681A (fr) |
| NZ (1) | NZ278201A (fr) |
| PL (1) | PL314984A1 (fr) |
| SK (1) | SK75796A3 (fr) |
| WO (1) | WO1995016688A1 (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7508196A (en) | 1995-11-13 | 1997-06-05 | Gerard Voerman | Anti-viral isolates obtainable from leeches |
| MY126358A (en) * | 1996-03-22 | 2006-09-29 | Glaxo Group Ltd | Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs |
| TW438799B (en) * | 1997-05-29 | 2001-06-07 | Merck & Co Inc | HIV protease inhibitor |
| ZA984514B (en) * | 1997-05-29 | 1998-11-30 | Merck & Co Inc | Hiv protease inhibitor |
| PL192361B1 (pl) * | 1997-08-25 | 2006-10-31 | Boehringer Ingelheim Pharma | Kompozycja farmaceutyczna hemihydratu newirapiny i sposób wytwarzania wodnej zawiesiny hemihydratu newirapiny |
| US6180634B1 (en) | 1997-11-13 | 2001-01-30 | Merck & Co., Inc. | Combination therapy for the treatment of AIDS |
| CO4970782A1 (es) * | 1997-11-13 | 2000-11-07 | Merck & Co Inc | Terapia combinada para el tratamiento del sida |
| US6251906B1 (en) | 1998-05-15 | 2001-06-26 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| FR2780649B1 (fr) * | 1998-07-06 | 2001-03-09 | Univ Paris Vii Denis Diderot | Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine |
| GB2341385A (en) | 1998-09-14 | 2000-03-15 | Merck & Co Inc | Recovery of iodide from chemical process waste water |
| US6440946B1 (en) * | 1999-02-25 | 2002-08-27 | Takeda Chemical Industries, Ltd. | Multiple-agents-binding compound, production and use thereof |
| US6589962B1 (en) | 1999-07-20 | 2003-07-08 | Merck & Co., Inc. | Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| US6642237B1 (en) | 1999-11-24 | 2003-11-04 | Merck & Co., Inc. | Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof |
| US6482952B2 (en) | 2000-06-20 | 2002-11-19 | Merck & Co., Inc. | Process for preparing acetonides |
| US7049146B2 (en) | 2000-11-14 | 2006-05-23 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US7122376B2 (en) * | 2001-11-01 | 2006-10-17 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US20040131504A1 (en) * | 2002-09-17 | 2004-07-08 | Landers James P. | Remote temperature sensing of small volume and related apparatus thereof |
| GB0720503D0 (en) * | 2007-10-22 | 2007-11-28 | Angeletti P Ist Richerche Bio | New compound |
| CN114010776A (zh) | 2010-06-09 | 2022-02-08 | 疫苗技术股份有限公司 | 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫 |
| CN108178764A (zh) * | 2018-01-09 | 2018-06-19 | 天津科技大学 | 呋喃并[2,3-b]吡啶类化合物及无金属催化的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
| WO1993008184A1 (fr) * | 1991-10-23 | 1993-04-29 | Merck & Co., Inc. | Inhibiteurs de la protease du vih______________________ |
| ATE163926T1 (de) * | 1991-11-08 | 1998-03-15 | Merck & Co Inc | Hiv-protease-inhibitoren verwendbar in der aids- behandlung |
| US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| RO118000B1 (ro) * | 1993-03-31 | 2002-12-30 | Merck & Co Inc | Metoda pentru tratamentul sida, prevenirea si tratamentul infectiei cu hiv sau inhibarea proteazei hiv si compozitie farmaceutica pentru aplicarea metodei |
-
1994
- 1994-12-12 JP JP7516855A patent/JP3000564B2/ja not_active Expired - Fee Related
- 1994-12-12 AU AU14331/95A patent/AU692509B2/en not_active Ceased
- 1994-12-12 FI FI962488A patent/FI962488A0/fi unknown
- 1994-12-12 NZ NZ278201A patent/NZ278201A/en unknown
- 1994-12-12 SK SK757-96A patent/SK75796A3/sk unknown
- 1994-12-12 HU HU9601649A patent/HUT74681A/hu unknown
- 1994-12-12 EP EP95905886A patent/EP0734387B1/fr not_active Expired - Lifetime
- 1994-12-12 AT AT95905886T patent/ATE215952T1/de not_active IP Right Cessation
- 1994-12-12 BR BR9408305A patent/BR9408305A/pt not_active Application Discontinuation
- 1994-12-12 DE DE69430385T patent/DE69430385T2/de not_active Expired - Fee Related
- 1994-12-12 CN CN94194954A patent/CN1046727C/zh not_active Expired - Fee Related
- 1994-12-12 WO PCT/US1994/014187 patent/WO1995016688A1/fr not_active Ceased
- 1994-12-12 ES ES95905886T patent/ES2174921T3/es not_active Expired - Lifetime
- 1994-12-12 KR KR1019960703165A patent/KR100234863B1/ko not_active Expired - Fee Related
- 1994-12-12 CZ CZ19961586A patent/CZ288312B6/cs not_active IP Right Cessation
- 1994-12-12 CA CA002178760A patent/CA2178760C/fr not_active Expired - Fee Related
- 1994-12-12 PL PL94314984A patent/PL314984A1/xx unknown
-
1995
- 1995-03-29 US US08/412,509 patent/US5646148A/en not_active Expired - Fee Related
-
1996
- 1996-06-05 BG BG100643A patent/BG62093B1/bg unknown
-
1997
- 1997-04-08 US US08/825,787 patent/US5807841A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| SK75796A3 (en) | 1997-05-07 |
| CN1142827A (zh) | 1997-02-12 |
| DE69430385T2 (de) | 2002-11-07 |
| WO1995016688A1 (fr) | 1995-06-22 |
| NZ278201A (en) | 1998-01-26 |
| AU692509B2 (en) | 1998-06-11 |
| PL314984A1 (en) | 1996-09-30 |
| EP0734387A4 (fr) | 1997-03-05 |
| HUT74681A (en) | 1997-01-28 |
| FI962488L (fi) | 1996-06-14 |
| EP0734387B1 (fr) | 2002-04-10 |
| JP3000564B2 (ja) | 2000-01-17 |
| CA2178760C (fr) | 2000-08-01 |
| ES2174921T3 (es) | 2002-11-16 |
| FI962488A7 (fi) | 1996-06-14 |
| CZ288312B6 (en) | 2001-05-16 |
| HU9601649D0 (en) | 1996-08-28 |
| JPH09506619A (ja) | 1997-06-30 |
| CZ158696A3 (en) | 1996-11-13 |
| FI962488A0 (fi) | 1996-06-14 |
| BG100643A (bg) | 1997-02-28 |
| EP0734387A1 (fr) | 1996-10-02 |
| DE69430385D1 (de) | 2002-05-16 |
| BR9408305A (pt) | 1997-08-26 |
| CA2178760A1 (fr) | 1995-06-22 |
| CN1046727C (zh) | 1999-11-24 |
| AU1433195A (en) | 1995-07-03 |
| US5807841A (en) | 1998-09-15 |
| US5646148A (en) | 1997-07-08 |
| ATE215952T1 (de) | 2002-04-15 |
| KR100234863B1 (ko) | 1999-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG62093B1 (bg) | Инхибитори на hiv протеаза | |
| EP0617968B1 (fr) | Inhibiteurs de protease de l'HIV en mélanges pharmaceutiques pour le traitement du SIDA | |
| AU676563B2 (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| EP0766674B1 (fr) | Nouveaux inhibiteurs de protease de vih | |
| JP2020505327A (ja) | Ｅｇｆｒタンパク質分解標的化キメラ分子およびその関連する使用方法 | |
| JP2020505327A5 (fr) | ||
| EP2168958A1 (fr) | Composés d'isoindole-imide, compositions et leurs utilisations | |
| US5650412A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| CA2269135A1 (fr) | Derives de benzodiazepine hydrazide utilises comme inhibiteurs de l'integrase du vih | |
| WO1994026749A1 (fr) | Inhibiteurs de la protease de vih | |
| RU2137768C1 (ru) | Ингибиторы hiv протеазы | |
| HK1009248B (en) | Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids | |
| HK1102331A (en) | N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1h-isoindolin-4-yl)methyl}cyclopropylcarboxamide as tnf inhibitor |